Enterprise Value
17.21B
Cash
1.152B
Avg Qtr Burn
N/A
Short % of Float
3.75%
Insider Ownership
0.48%
Institutional Own.
-
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PDUFA Approval decision | ||
VOXZOGO Details Genetic Short Stature Conditions | Phase 2 Data readout |